Physician profile
Lance S Lim
NPI 1013914209
$469.15
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.14 · 2020: $88.44 · 2021: $121 · 2022: $85.01 · 2023: $117 · 2024: $34.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $151.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $179.94 | 2020-2023 | |
| Lilly USA, LLC | $77.74 | 2021-2024 | Mounjaro |
| Novo Nordisk INC | $62.42 | 2019-2021 | |
| Exact Sciences Corporation | $51.60 | 2023-2024 | Cologuard Collection Kit |
| Mylan Specialty L.P. | $27.88 | 2021 | |
| Abbvie INC. | $22.83 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $16.83 | 2023 | Eliquis |
| Ultragenyx Pharmaceutical INC. | $15.24 | 2023 | |
| Janssen Pharmaceuticals, INC | $14.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.